Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction
Open Access
- 1 March 2001
- journal article
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 2 (1_suppl) , S204-S210
Abstract
Angiotensin II (Ang II) type 1 (AT1) receptor blockers differ in their affinity for the AT1-receptor, suggesting a dissimilar potency for inhibiting Ang II-induced vascular constriction. In the present study, we compared the effects of candesartan, irbesartan and losartan on the renal microvascular constriction to locally-formed Ang II, using isolated, perfused hydronephrotic rat kidneys. Addition of 1 nmol/L angiotensin I (Ang I, the precursor of Ang II) significantly reduced the diameters of interlobular arteries (ILAs; -47.6±2.6%), afferent arterioles (AAs; -43.6±2.3%) and efferent arterioles (EAs; -31.6±2.4%). Candesartan and irbesartan were more potent in antagonising the constriction to Ang I than losartan. By contrast, candesartan and irbesartan differed only slightly in potency. After a washing period of 60 minutes with drug-free medium, a second application of Ang I failed to induce vasoconstriction only in candesartan-treated kidneys. Pretreatment of hydronephrotic kidneys with candesartan, to further explore its antagonistic properties, shifted the dose-response curves of Ang II approximately 2 log units to the right without reducing the maximal Ang II-induced constriction of ILAs, AAs or EAs. Additionally, dose-response curves of Ang II were similar after short (10 minutes) and prolonged (60 minutes) preincubation with candesartan. Our findings indicate that candesartan and irbesartan are more potent inhibitors of renal microvascular constriction to locally-formed Ang II than losartan. The inhibitory effect of candesartan is more prolonged, suggesting a slow dissociation from the AT1-receptor. Additionally, candesartan was found to block the Ang II-induced constriction of renal microvessels in a surmountable manner.Keywords
This publication has 15 references indexed in Scilit:
- In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartanAmerican Journal of Hypertension, 2000
- Mechanistic Differences of Various AT1-Receptor Blockers in Isolated Vessels of Different OriginHypertension, 1999
- Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO‐K1 cells expressing human angiotensin II AT1 receptorsBritish Journal of Pharmacology, 1999
- Video-microscopic Assessment of the Role of Tissue Angiotensin-converting Enzyme in the Control of the Renal MicrocirculationThe Journal of Pharmacology and Experimental Therapeutics, 1997
- Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptorEuropean Journal of Pharmacology, 1997
- Characterization of the Angiotensin II Receptor Antagonist TCV-116 in Healthy VolunteersHypertension, 1995
- Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistBiochemical Pharmacology, 1993
- Angiotensin actions in the kidney: Renewed insight into the old hormoneKidney International, 1991
- Characterization of the Renal Microvascular Effects of Angiotensin II Antagonist, DuP 753:American Journal of Hypertension, 1991
- Hydronephrosis: A new method to visualize vas afferens, efferens, and glomerular networkKidney International, 1983